SBO-154

N/A

Report date: 2025/06/30 20:00:06

Base Information

Drug NameSBO-154
Drug Alias NameSBO-154
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-MUC1
TargetsMucin-1
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Advanced Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSun Pharma Advanced Research Company LtdSun Pharmaceutical Advanced Research Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A